The putative role of the intestinal microbiota in the irritable bowel syndrome

Digestive and Liver Disease

Volumn 41, Issue 12, 2009, Pages 850-853

  Collins, S M ^a   Denou, E ^a   Verdu, E F ^a   Bercik, P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bacteria; Flora; Functional GI disorders; Gastroenteritis; Inflammation; Motility; Pain

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL DISEASE; BEHAVIOR CHANGE; BRAIN FUNCTION; CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY; CROHN DISEASE; DIET; DISEASE SEVERITY; DRUG USE; ENTERITIS; HOST; HUMAN; HYPOTHESIS; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INFECTION; IRRITABLE COLON; MENTAL DISEASE; MUCOSA INFLAMMATION; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SHORT SURVEY; TISSUE INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; IRRITABLE BOWEL SYNDROME; RISK FACTORS;

EID: 70350566110     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.07.023     Document Type: Short Survey

References (59)

1. Lea R., and Whorwell P.J. Quality of life in irritable bowel syndrome. Pharmacoeconomics 19 (2001) 643-653
2. Lydiard R.B. Irritable bowel syndrome, anxiety, and depression: what are the links?. J Clin Psychiatry 62 (2001) 38-45 [discussion 46-7.38-45]
3. Spiegel B., Schoenfeld P., and Naliboff B. Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome. Aliment Pharmacol Ther 26 (2007) 183-193
4. Boivin M. Socioeconomic impact of irritable bowel syndrome in Canada. Can J Gastroenterol 15 (2001) 8B-11B, 8B-11B
5. Dapoigny M., Bellanger J., Bonaz B., et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 16 (2004) 995-1001
6. Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm 10 (2004) 299-309
7. Sanger G.J., and Alpers D.H. Development of drugs for gastrointestinal motor disorders: translating science to clinical need. Neurogastroenterol Motil 20 (2008) 177-184
8. Folks D.G. The interface of psychiatry and irritable bowel syndrome. Curr Psychiatry Rep 6 (2004) 210-215
9. Garakani A., Win T., Virk S., et al. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther 10 (2003) 61-67
10. Chaudhary N.A., and Truelove S.C. The irritable bowel syndrome. Quart J Med 31 (1962) 307-322
11. Stewart G.T. Post-dysenteric colitis. British Medical Journal 3 (1950) 405-409
12. McKendrick M.W., and Read N.W. Irritable bowel syndrome-post salmonella infection. J Infect 29 (1994) 1-3
13. Gwee K.A., Graham J.C., McKendrick M.W., et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea [see comments]. Lancet 347 (1996) 150-153
14. Gwee K.A., Leong Y.L., Graham C., et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44 (1999) 400-406
15. Gwee K.A., Collins S.M., Read N.W., et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 52 (2003) 523-526
16. Collins S.M., Vallance B., Barbara G., et al. Putative inflammatory and immunological mechanisms in functional bowel disorders. Baillieres Best Pract Res Clin Gastroenterol 13 (1999) 429-436
17. Collins S.M. Is the irritable gut an inflamed gut?. Scand J Gastroenterol Suppl 192 (1992) 102-105
18. Collins S.M. The immunomodulation of enteric neuromuscular function; implications for motility and inflammatory disorders. Gastroenterology 111 (1996) 1683-1689
19. Barbara G., Vallance B.A., and Collins S.M. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 113 (1997) 1224-1232
20. Bercik P., Wang L., Verdu E.F., et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 127 (2004) 179-187
21. Barbara G., De Giorgio R., Deng Y., et al. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 120 (2001) 1729-1736
22. Verdu E.F., Bercik P., Bergonzelli G.E., et al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 127 (2004) 826-837
23. Weston A.P., Biddle W.L., Bhatia P.S., et al. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 38 (1993) 1590-1595
24. Barbara G., Stanghellini V., De Giorgio R., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004) 693-702
25. Tornblom H., Lindberg G., Nyberg B., et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 123 (2002) 1972-1979
26. Barbara G., Wang B., Stanghellini V., et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132 (2007) 26-37
27. Piche T., Barbara G., Aubert P., et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58 (2009) 196-201
28. Marshall J.K.F., Thabane M.F., Garg A.X.F., et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 20 (2004) 1317-1322
29. Spiller R.C., Jenkins D., and Thornley J.P. Increased rectal mucosal enteroendocrine cells, T lymphocytes and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47 (2000) 804-811
30. Pimentel M., Chow E.J., and Lin H.C. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 95 (2000) 3503-3506
31. King T.S., Elia M., and Hunter J.O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352 (1998) 1187-1189
32. Kassinen A., Krogius-Kurikka L., Makivuokko H., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133 (2007) 24-33
33. Malinen E., Rinttila T., Kajander K., et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100 (2005) 373-382
34. Matto J., Maunuksela L., Kajander K., et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43 (2005) 213-222
35. Backhed F., Ley R.E., Sonnenburg J.L., et al. Host-bacterial mutualism in the human intestine. Science 307 (2005) 1915-1920
36. Hooper L.V., and Gordon J.I. Commensal host-bacterial relationships in the gut. Science 292 (2001) 1115-1118
37. Amaral F.A., Sachs D., Costa V.V., et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci USA 105 (2008) 2193-2197
38. Backhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101 (2004) 15718-15723
39. Dumas M.E., Barton R.H., Toye A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103 (2006) 12511-12516
40. Hawrelak J.A., and Myers S.P. The causes of intestinal dysbiosis: a review. Altern Med Rev 9 (2004) 180-197
41. Jacobs Jr. N.F. Antibiotic-induced diarrhea and pseudomembranous colitis. Postgrad Med 95 (1994) 111-120
42. Lepage P., Colombet J., Marteau P., et al. Dysbiosis in inflammatory bowel disease: a role for bacteriophages?. Gut 57 (2008) 424-425
43. Ledochowski M., Widner B., Bair H., et al. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 35 (2000) 1048-1052
44. Dupont J.R., Jervis H.R., and Sprinz H. Auerbach's plexus of the rat cecum in relation to the germ free state. J Comp Neurol 125 (1965) 11-18
45. Husebye E., Hellstrom P.M., and Midtvedt T. Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig Dis Sci 39 (1994) 946-956
46. Bar F., von Koschitzky H., and Roblick U. Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol Motil (2009)
47. Guarino M.P., Altomare A., Stasi E., et al. Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells. J Clin Gastroenterol 42 (2008) S185-S190
48. Kamiya T., Wang L., Forsythe P., et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55 (2006) 191-196
49. Kunze W.A., Mao Y.K., Wang B., et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium dependent potassium channel opening. J Cell Mol Med (2009)
50. Lesniewska V., Rowland I., Laerke H.N., et al. Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo. Exp Physiol 91 (2006) 229-237
51. Verdu E.F., Bercik P., Verma-Gandhu M., et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55 (2006) 182-190
52. Scott L.D., and Cahall D.L. Influence of the interdigestive myoelectical complex on enteric flora in the rat. Gastroenterology 82 (1982) 737-745
53. Vantrappen G., Jannssens J., Hellemans J., et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. JCI 59 (1977) 1158-1168
54. Ruigomez A., Garcia Rodriguez L.A., and Panes J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of co-morbidities. Clin Gastroenterol Hepatol 5 4 (2007) 465-469
55. Shepherd S.J., Parker F.C., Muir J.G., et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 6 (2008) 765-771
56. Mendall M.A., and Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 10 (1998) 59-62
57. Sudo N., Chida Y., Aiba Y., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558 (2004) 263-275
58. Li W., Dowd S.E., Scurlock B., et al. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 96 (2009) 557-567
59. Collins S.M., and Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136 6 (2009) 2003-2014